Imagene AI

About:

Imagene provides AI-based molecular testing for cancer, detecting in real-time, a broad range of cancerous biomarkers from the biopsy image

Website: https://imagene-ai.com

Twitter/X: Imagene_ai

Top Investors: Blumberg Capital, Larry Ellison, Eyal Gura, David Agus

Description:

Imagene AI provides AI-based molecular testing for cancer, leveraging the patient's histological data for personalized therapy. Our mission at Imagene is to assist cancer patients in receiving the optimal treatment medicine can offer by leveraging AI to detect, in real-time, a broad range of cancerous biomarkers and genomic insights from the biopsy image alone. By doing so, Imagene overcomes economical, logistical, and technological barriers to reach the full potential of precision medicine for cancer patients. Through collaborations with top-tier medical centers and pharmaceutical companies, Imagene is revolutionizing molecular screening for both clinical practice and research. Our success derives from our cutting-edge technology and talented multidisciplinary team of data scientists, biologists, software engineers, and medical experts.